explore -WSS

explore

author：Wikipedia 2025-09-29 19:58:24 - browse：9

Daniel M. Skovronsky on stage at the 2023 STAT Summit. — Dan Skovronsky, Eli Lilly's chief scientific officer, at the 2023 STAT Summit. STAT

PHILADELPHIA — In a sense, the annual meeting of the American Heart Association wasn’t a huge one for Eli Lilly. Its biggest news was about a very early study of a drug to lower blood levels of Lp(a), a protein related to cholesterol that is mainly being watched by lipidologists and drug company analysts.

But in another way, the future of Lilly, now the biggest drug company by market capitalization, hung in the balance. Why? Because researchers were presenting data on the ability of Novo Nordisk’s obesity drug Wegovy to prevent heart attacks, strokes, and deaths in people with overweight who have established cardiovascular disease. That has big implications for the market for Lilly’s own obesity drug, Zepbound, which was approved by the Food and Drug Administration last week, and for the company’s future efforts in obesity.

STAT sat down with Lilly’s chief scientific officer, Dan Skovronsky, at the AHA meeting to talk about the obesity drugs known as GLP-1s, the new Lp(a) drug, and the company’s partnership with the gene editing firm Verve. An edited transcript of the conversation follows.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Resistance to cancer drugs: A new genetic explanation

WSS

As health system earnings go up, health insurance stocks go down

Is it ever OK for doctors to lie to their patients?

Suspected Gilgo Beach killer appeared 'traumatized' after arrest: Defense attorney

Man who had jail sentence commuted by Trump arrested again

Norman Reedus' Daryl Dixon

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

explore

explore

Wikipedia

The high cost of giving birth even with insurance

Black vets could get higher VA benefits if race not used in lung test

New air purifier tech could be key to improving indoor air quality

Stanford president to resign after investigation of research

Drug repurposing or repositioning? The language matters

DOJ, FTC to increase scrutiny of all types of health care mergers

Medicare details structure of new drug price negotiation program

GSK’s asthma push continues as drug succeeds in Phase 3 trials

Novavax promises a turnaround & Lilly roils the obesity market

Suspected Gilgo Beach killer appeared 'traumatized' after arrest: Defense attorney

hotspot

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

Brain MRIs reveal impact of 'toxic stress' on Black children

BIO to announce reorganization, senior leaders expected to depart

Class action alleges UnitedHealth concealed DOJ probe

Celebrate National Dole Whip Day for 3 days this week at Disney

Why the Crimean Bridge is key to Russia's war in Ukraine

hotspot

focus

entertainment

knowledge